Dr. Jorge Eduardo Berrio, Labor Hero of the Republic of Cuba and director of the center, told reporters that during the pandemic, the unit attended to 8,567 patients, 4,279 of whom were confirmed with SARS CoV-2.
Berrio pointed out that for this new stage, in which they will provide services in most healthcare areas, the hospital has embarked in seven scientific projects, whose application began during the Covid-19 pandemic.
“These projects arise from the use of some drugs to treat respiratory diseases such as the application of the monoclonal antibody Itolizumab,” he said.
He emphasized that other research projects will be added, including the use of Jusvinza or CIGB-258, which is used in cases of severe patients so that they do not refer to the critical, and even decrease mortality.
“We are also adding the use of erythropoietin as a stimulating factor and organic protector against comorbidities, without ruling out the usefulness of plasmapheresis in respiratory cases, in coordination with the Provincial Blood Bank,” he pointed out.
Dr. Berrio noted that the hospital also prioritizes specialties for outpatient care to patients with sequelae of Covid-19, such as respiratory, cardiac, renal diseases, joint pain due to neuropathy, as well as the comorbidities accentuated by the coronavirus.
“We will continue to attend to patients from central Villa Clara province, as well as other people from other Cuban central region,” Dr. Berrio concluded.